Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Entain's BetMGM swings to profit as Q1 revenues rise

(Sharecast News) - Entain reported a jump in revenue at BetMGM and a swing to profit on Monday as momentum from the second half carried into the first quarter. Entain said the US sports betting and iGaming operator - a joint venture with MGM Resorts - saw net revenue rise 34% year-on-year in the three months to the end of March, driven by its "leading iGaming offering and strengthened sports product, and refined approach to player management".

The company pointed to strong growth across both iGaming and online sports, which saw increases of 27% and 68%, respectively.

BetMGM swung to a core profit of $22m in the first quarter, versus a loss of $132m in the same period the year before.

Entain, which also owns Ladbrokes, said positive first-quarter earnings before interest, tax, depreciation and amortisation and underlying trends reaffirm confidence that FY2025 will be EBITDA positive. It also reaffirmed guidance for net revenue of $2.4bn to $2.5bn.

Adam Greenblatt, chief executive officer of BetMGM, said: "2025 is off to an encouraging start for BetMGM as we execute our revised strategic plan. The momentum we built in the second half of 2024 continued into the first quarter as we implement our powerful iGaming strategy, enabling us to grow faster than the market and at scale.

"In Online Sports, we are elevating our brand and delivering improved performance, even in the face of unfavourable sports outcomes during key moments in the quarter. As we approach May, we remain confident in achieving full year positive EBITDA in 2025, supported by solid underlying activity trends and our successful delivery of positive EBITDA in the first quarter."

At 1250 BST, the shares were up 6.4% at 625.98p.

Entain is due to publish a first-quarter trading update on Tuesday.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.